Foreign4 months ago
Pfizer Withdraws $125,000 Sickle Cell Treatment Oxbryta Worldwide
Pfizer has announced the global withdrawal of its sickle cell disease treatment, Oxbryta (voxelotor), which was priced at approximately $125,000 per year. The decision follows a...
